Strategies to Reduce Hospital Readmissions

Sakkarin Chirapongsathorn, Jayant A. Talwalkar, Patrick Sequeira Kamath

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

After the Patient Protection and Affordable Care Act or Obamacare was signed into law in 2010, the problem of readmission has taken on a new sense of urgency. Hospitals with excess readmissions receive reduced reimbursement because readmission is considered to represent a poor quality measure in the healthcare delivery system. Cirrhosis places a major burden on the healthcare economy. Patients with cirrhosis frequently require hospitalization, and annual admission rates have doubled within 10 years. The costs of hospitalization associated with cirrhosis have also markedly increased. Readmissions create negative consequences for the patient and the family. Several strategies have been proposed to reduce the number of readmissions, but the efficacy of these strategies is questionable. Although the Model for End-Stage of Liver Disease (MELD) score can be a tool for risk stratification, many other factors are also independent risks for readmission. Studies aimed at the reduction of readmission in patients with cirrhosis are very limited, and much research is required before specific recommendations can be made to reduce readmissions.

Original languageEnglish (US)
Pages (from-to)161-166
Number of pages6
JournalSeminars in Liver Disease
Volume36
Issue number2
DOIs
StatePublished - May 1 2016

Fingerprint

Patient Readmission
Fibrosis
Patient Protection and Affordable Care Act
Delivery of Health Care
Hospitalization
End Stage Liver Disease
Costs and Cost Analysis
Research

Keywords

  • cirrhosis
  • complications of cirrhosis
  • healthcare delivery
  • MELD score
  • readmission

ASJC Scopus subject areas

  • Hepatology

Cite this

Strategies to Reduce Hospital Readmissions. / Chirapongsathorn, Sakkarin; Talwalkar, Jayant A.; Kamath, Patrick Sequeira.

In: Seminars in Liver Disease, Vol. 36, No. 2, 01.05.2016, p. 161-166.

Research output: Contribution to journalArticle

Chirapongsathorn, Sakkarin ; Talwalkar, Jayant A. ; Kamath, Patrick Sequeira. / Strategies to Reduce Hospital Readmissions. In: Seminars in Liver Disease. 2016 ; Vol. 36, No. 2. pp. 161-166.
@article{6ef4584c03af45ac85e4d05b072021a8,
title = "Strategies to Reduce Hospital Readmissions",
abstract = "After the Patient Protection and Affordable Care Act or Obamacare was signed into law in 2010, the problem of readmission has taken on a new sense of urgency. Hospitals with excess readmissions receive reduced reimbursement because readmission is considered to represent a poor quality measure in the healthcare delivery system. Cirrhosis places a major burden on the healthcare economy. Patients with cirrhosis frequently require hospitalization, and annual admission rates have doubled within 10 years. The costs of hospitalization associated with cirrhosis have also markedly increased. Readmissions create negative consequences for the patient and the family. Several strategies have been proposed to reduce the number of readmissions, but the efficacy of these strategies is questionable. Although the Model for End-Stage of Liver Disease (MELD) score can be a tool for risk stratification, many other factors are also independent risks for readmission. Studies aimed at the reduction of readmission in patients with cirrhosis are very limited, and much research is required before specific recommendations can be made to reduce readmissions.",
keywords = "cirrhosis, complications of cirrhosis, healthcare delivery, MELD score, readmission",
author = "Sakkarin Chirapongsathorn and Talwalkar, {Jayant A.} and Kamath, {Patrick Sequeira}",
year = "2016",
month = "5",
day = "1",
doi = "10.1055/s-0036-1583196",
language = "English (US)",
volume = "36",
pages = "161--166",
journal = "Seminars in Liver Disease",
issn = "0272-8087",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Strategies to Reduce Hospital Readmissions

AU - Chirapongsathorn, Sakkarin

AU - Talwalkar, Jayant A.

AU - Kamath, Patrick Sequeira

PY - 2016/5/1

Y1 - 2016/5/1

N2 - After the Patient Protection and Affordable Care Act or Obamacare was signed into law in 2010, the problem of readmission has taken on a new sense of urgency. Hospitals with excess readmissions receive reduced reimbursement because readmission is considered to represent a poor quality measure in the healthcare delivery system. Cirrhosis places a major burden on the healthcare economy. Patients with cirrhosis frequently require hospitalization, and annual admission rates have doubled within 10 years. The costs of hospitalization associated with cirrhosis have also markedly increased. Readmissions create negative consequences for the patient and the family. Several strategies have been proposed to reduce the number of readmissions, but the efficacy of these strategies is questionable. Although the Model for End-Stage of Liver Disease (MELD) score can be a tool for risk stratification, many other factors are also independent risks for readmission. Studies aimed at the reduction of readmission in patients with cirrhosis are very limited, and much research is required before specific recommendations can be made to reduce readmissions.

AB - After the Patient Protection and Affordable Care Act or Obamacare was signed into law in 2010, the problem of readmission has taken on a new sense of urgency. Hospitals with excess readmissions receive reduced reimbursement because readmission is considered to represent a poor quality measure in the healthcare delivery system. Cirrhosis places a major burden on the healthcare economy. Patients with cirrhosis frequently require hospitalization, and annual admission rates have doubled within 10 years. The costs of hospitalization associated with cirrhosis have also markedly increased. Readmissions create negative consequences for the patient and the family. Several strategies have been proposed to reduce the number of readmissions, but the efficacy of these strategies is questionable. Although the Model for End-Stage of Liver Disease (MELD) score can be a tool for risk stratification, many other factors are also independent risks for readmission. Studies aimed at the reduction of readmission in patients with cirrhosis are very limited, and much research is required before specific recommendations can be made to reduce readmissions.

KW - cirrhosis

KW - complications of cirrhosis

KW - healthcare delivery

KW - MELD score

KW - readmission

UR - http://www.scopus.com/inward/record.url?scp=84967110072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84967110072&partnerID=8YFLogxK

U2 - 10.1055/s-0036-1583196

DO - 10.1055/s-0036-1583196

M3 - Article

C2 - 27172358

AN - SCOPUS:84967110072

VL - 36

SP - 161

EP - 166

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

SN - 0272-8087

IS - 2

ER -